Hypofractionated radiotherapy in locally advanced bladder cancer: an individual patient data meta-analysis of the BC2001 and BCON trials

BACKGROUND: Two radiotherapy fractionation schedules are used to treat locally advanced bladder cancer: 64 Gy in 32 fractions over 6·5 weeks and a hypofractionated schedule of 55 Gy in 20 fractions over 4 weeks. Long-term outcomes of these schedules in several cohort studies and case series suggest...

Descripción completa

Detalles Bibliográficos
Autores principales: Choudhury, Ananya, Porta, Nuria, Hall, Emma, Song, Yee Pei, Owen, Ruth, MacKay, Ranald, West, Catharine M L, Lewis, Rebecca, Hussain, Syed A, James, Nicholas D, Huddart, Robert, Hoskin, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lancet Pub. Group 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7851111/
https://www.ncbi.nlm.nih.gov/pubmed/33539743
http://dx.doi.org/10.1016/S1470-2045(20)30607-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7851111/
https://www.ncbi.nlm.nih.gov/pubmed/33539743
http://dx.doi.org/10.1016/S1470-2045(20)30607-0

Ejemplares similares